Company: RPTX
Filing Date: 2025-11-17
Form Type: DEFA14A
Source: 0001193125-25-284040
Chunk: 62

Company: Repare Therapeutics Inc.
Filing Date: 2025-11-17
Form: DEFA14A
Chunk 62
---
 or oral agreement, arrangement or understanding) any inquiry, proposal or 
 offer that constitutes or could reasonably be expected to constitute an Acquisition Proposal;                                                                                                                                                           |

| (ii) | enter into, continue or otherwise participate or engage in or otherwise facilitate any discussions or                                                                                                                                                 
 negotiations with any person (other than the Purchaser, Parent and their respective affiliates and Representatives), or otherwise cooperate in any way with, or assist or participate in, encourage or otherwise facilitate, any inquiry, proposal or 
 offer that constitutes or could reasonably be expected to constitute an Acquisition Proposal, provided that, for greater certainty, the Company may (A) communicate with any person making an unsolicited Acquisition Proposal (and such              
 person’s Representatives) for the purposes of clarifying the terms and conditions of such Acquisition Proposal and assessing the likelihood of its consummation so as to determine whether such Acquisition Proposal constitutes or could             
 reasonably be expected to constitute or lead to a Superior Proposal, (B) advise any person of the restrictions of this Agreement, and (C) advise any person making an unsolicited Acquisition Proposal that such Acquisition Proposal does not        
 constitute a Superior Proposal when the Board of Directors has so determined;                                                                                                                                                                         |

- 35 -

| (iii) | make a Change of Recommendation; or |

| (iv) | accept, approve, endorse, recommend or enter into, or publicly propose to accept, approve, endorse, recommend                                                                                                                                           
 or enter into, any letter of intent, agreement in principle, agreement, arrangement or undertaking (other than a confidentiality and standstill agreement permitted under Section 6.2) constituting an Acquisition Proposal or requiring, or            
 reasonably expected to cause, the Company to abandon, terminate, delay or fail to consummate, or that would otherwise impede, interfere or be inconsistent with, the Arrangement or any of the other transactions contemplated by this Agreement or     
 requiring, or reasonably expected to cause, the Company to fail to comply with this Agreement or providing for the payment of any break, termination or other fees or expenses to any person in the event that any of the Contemplated Transactions are 
 completed or in the event that it completes any other transaction with the Purchaser or any of its affiliates that is agreed to prior to any termination of this Agreement.                                                                             |

| (b) | The Company shall, and shall cause each of its Subsidiary and its and its Subsidiary’s Representatives                                                                                                                                                   
 to, immediately cease and terminate any existing solicitation, assistance, discussion, encouragement, activities, negotiation or